93-9472 Pill - orange round
Pill with imprint 93-9472 is Orange, Round and has been identified as Pemoline 75 mg. It is supplied by Teva Pharmaceuticals USA.
Pemoline is used in the treatment of ADHD and belongs to the drug class CNS stimulants. There is no proven risk in humans during pregnancy. Pemoline 75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for 93-9472
Pemoline
- Imprint
- 93-9472
- Strength
- 75 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-9472 (Discontinued)
See also:
Adderall
Adderall (amphetamine and dextroamphetamine) is used to treat narcolepsy and ADHD. Includes side ...
Vyvanse
Vyvanse is a prescription stimulant used to treat ADHD in children and adults, and binge eating ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Strattera
Strattera (atomoxetine) is used to treat attention deficit hyperactivity disorder. Learn about side ...
Concerta
Concerta is used to treat attention deficit disorder (ADD) and attention deficit hyperactivity ...
Ritalin
Ritalin (methylphenidate) is used to treat attention deficit disorder (ADD) and narcolepsy ...
Focalin
Focalin (dexmethylphenidate) is used to treat attention deficit hyperactivity disorder (ADHD) ...
Amphetamine/dextroamphetamine
Amphetamine/dextroamphetamine is used for ADHD, fatigue, narcolepsy
Lisdexamfetamine
Lisdexamfetamine is used for ADHD, asperger syndrome, binge eating disorder, chronic fatigue ...
More about pemoline
- Check interactions
- Compare alternatives
- Reviews (19)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: CNS stimulants
Patient resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.